• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • TheStreet Smarts
  1. Home
  2. / Investing
  3. / Stocks

In a Market Yet to Bottom, I Like Deep Value Stocks and This Defense Sector

I still believe equities have another leg down before we find a bottom.
By BRET JENSEN
Jul 15, 2022 | 10:00 AM EDT
Stocks quotes in this article: JPM, TOL, MRK, BMY, GS, BAC

Banks like JPMorgan Chase  (JPM) kicked off what is likely to be a disappointing, if not outright dismal second-quarter earnings reporting season. JPM's results missed both top and bottom-line expectations and the company suspended its stock buyback program. The stock lost more than 3% in trading Thursday as a result.

My regular readers know that I have been banging the drum for months that the combination of surging prices and a fast-slowing economy was going to produce more negative impacts to profit margins that most analysts were factoring into their projections. Analyst firms are now acting fast to revise their too optimistic projections.

A Goldman Sachs (GS) analyst noted Thursday that 'Sell-side analysts are scrambling to get ahead of Q2 earnings; over the last 5 days they've downgraded more than 500 names (on a net basis). Since the Financial Crisis, there's only been 4 other weeks when that many names have been downgraded that quickly." Meanwhile the main strategist at Bank of America (BAC) slashed her S&P 500 estimate by 25% to 3600.

Things are hardly better in Europe where the euro has hit parity against the dollar for the first time in two decades. The prime minister in the U.K. just resigned and it appears the current government in Italy is also in danger of dissolving. Surging inflation is triggering large demonstrations in several regions of the continent.

For these reasons, I still believe equities have another leg down before we find a bottom.

I am sticking to deep value stocks for a good portion of the dry powder I am deploying on big down days in the markets. I'd rather have a high-quality homebuilder like Toll Brothers (TOL) selling for under five times earnings than a tech stock selling at 20-25 times profits based on 15% to 20% earnings growth that is more likely to be 5% to 10% as the country enters a recession. Even if earnings expectations for Toll Brothers take a significant hit, a lot of bad news is already priced into the shares.

I also like defensive sectors of the economy that won't see earnings projections take a big hit in a recessionary economy. Healthcare is one such area of the market where I have increased allocation to in recent months. Names like Merck (MRK) and Bristol-Myers Squibb (BMY) are two I have been accumulating. Neither is expensive and both pay around a 3% dividend yield to boot.

Almost all the new money I am putting into the market on dips is being done via covered call orders to provide an extra layer of downside protection. My cash allocation also remains just north of 20% in my portfolio. I believe this is a prudent stance given my view that the overall market hasn't hit bottom yet.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Bret Jensen was Long BMY, MRK and TOL.

TAGS: Earnings | Economy | Fundamental Analysis | Investing | Markets | Stocks | Trading | Value Investing | Housing Market | Healthcare | U.S. Equity

More from Stocks

Here's How to Lock in a Trade on a Promising Biopharma Name

Bret Jensen
Oct 1, 2023 7:15 AM EDT

This small-cap is developing a promising new gastrointestinal disease-fighting drug and has one already on the market, making it a great options play.

Elite Traders Make Big Profits Using This Trick

James "Rev Shark" DePorre
Sep 30, 2023 10:00 AM EDT

A concentrated position in the right stock at the right time is how you make exceptional profit. Here are the steps that pro traders employ to rack up huge gains.

FS Insight Weekly Roadmap: Q4 Shows Promise After 'Vortex of Pain'

Tom Lee and the FSI Team
Sep 30, 2023 9:06 AM EDT

Despite a high volume of noise, inflation remains the primary macro driver for markets, while a government shutdown could put the Fed on an automatic 'structural pause.'

3 Small-Cap Stocks With Big Dividends

Bob Ciura
Sep 30, 2023 7:00 AM EDT

These names provide shareholders with potential growth in addition to their dividends.

Here's Why Traders Are Cautious Despite Slowing Inflation

James "Rev Shark" DePorre
Sep 29, 2023 4:25 PM EDT

As we say to goodbye to a rough September, let's look what what's weighing on investor sentiment now.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 12:13 PM EDT BRUCE KAMICH

    8 Trading Rules from T. T. Hoyne

    You just read the header for this missive and prob...
  • 08:42 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    How Elite Traders Make Big Profits
  • 02:58 PM EDT BRUCE KAMICH

    Classic Trading Rules From Bernard Baruch

    Bernard Baruch listed the rules (below) in his aut...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2023 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login